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Abstract 
Background: We examined the characteristics of parents using an iPad-based intervention about vaccines, and its 
impact on vaccination attitudes and behavior.
Methods: Interventions were implemented in three primary care clinics from June 2012–September 2013. Baseline 
and follow up surveys assessed vaccination attitudes and intentions. Medical records were used to examine adoles-
cent vaccine uptake.
Results: During the study, 42 parents viewed tailored educational content. Users were generally positive about vac-
cines, though one out of five worried that vaccines caused more harm than good. Among the 16 parents completing 
the post-intervention survey, there was a slightly higher, non-statistically significant, mean vaccination intention after 
viewing the website than prior to viewing it for three of the four adolescent vaccines (all except tetanus–diphtheria–
acellular pertussis). Using the intervention did not increase the likelihood of adolescent vaccination.
Conclusions: Providing educational material via iPads in clinic waiting rooms does not appear to be an effective 
strategy for engaging parents about vaccines. Overall, parents’ interaction with TeenVaxScene was low, and had little 
impact on their vaccination attitudes and beliefs. However, use of TeenVaxScene did not appear to worsen parents’ 
attitudes about vaccines. New and creative ideas for engaging parents to use such educational materials are needed.
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Background
Recognizing that adolescence is a time of major risk for 
several important vaccine preventable diseases, [1] the 
Advisory Committee on Immunization Practices (ACIP) 
established the “adolescent platform” of vaccines in 2005. 
This platform includes the human papillomavirus (HPV), 
tetanus–acellular pertussis–diphtheria (Tdap), influenza, 
and meningococcal (MCV) vaccines. The ACIP recom-
mends Influenza vaccine to all adolescents yearly and the 
remaining three vaccines as part of routine preventive 
health care for 11–12  year olds, with catch up vaccina-
tion recommended for older adolescents who have not 
yet been vaccinated [2].
Healthy people 2020 established a goal coverage level 
of 80 % among adolescents for each of these four vaccines 
[3]. However, national studies indicate that while cover-
age among adolescents for Tdap and MCV vaccines have 
reached or nearly reached this level (86 and 78 % respec-
tively for 13–17 year olds as of 2013), utilization of HPV 
and Influenza vaccines is lagging significantly [4, 5].
Barriers to high adolescent vaccine coverage include 
parents being unaware of adolescents’ risk for vaccine 
preventable diseases, and negative parental attitudes 
about the safety and necessity of adolescent vaccines 
[6–12]. While these barriers must be overcome for high 
vaccination levels to be achieved, there is a paucity of 
research on interventions to do this. Intervention devel-
opment has been hindered by the difficulty in finding 
time during clinical encounters to adequately address 
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parents’ vaccine-related questions, and the wide variety 
of parents’ vaccination beliefs and informational needs.
One promising strategy that may begin to address this 
problem is that of “tailored messaging.” Tailored mes-
saging is based on the principal that when information 
is provided to the user in a way that feels personally 
relevant, that information will be more impactful and 
thus more likely to be acted upon. A large body of evi-
dence supports the effectiveness of tailored messaging in 
improving compliance with a variety of preventive health 
behaviors, [13, 14] and our prior research supports its 
potential to increase levels of adolescent vaccination [15, 
16].
Our group recently developed an educational website 
that provides individually-tailored information to parents 
of adolescent children about the four vaccines in the ado-
lescent platform. To our knowledge this website, called 
TeenVaxScene, is the first tailored messaging interven-
tion related to adolescent vaccination to be developed. 
The goals of this study were to better understand the 
characteristics of parents who used the TeenVaxScene 
website (described in detail previously [17]) when pro-
vided in outpatient pediatric clinic waiting rooms via 
iPads, whether using TeenVaxScene impacted parental 
attitudes and decision making about adolescent vacci-





During the study period (July 2012–Sept 2013), there 
were 6749 adolescent patients seen in the three prac-
tices. As reported elsewhere, relatively few parents inter-
acted with the intervention despite the implementation 
of several different types of recruitment strategies [17]. 
Table 1 shows the demographic characteristics of the 54 
parents who used TeenVaxScene during the study period, 
and includes the characteristics of these parents’ 74 ado-
lescent children. Participants were distributed equally 
across the three clinics (data not shown). Most were 
highly-educated, white females. A notably high propor-
tion of parents, as well as their adolescent children, had 
personally experienced influenza in the past (Table  1). 
Among parents, 74 and 68 %, respectively, indicated that 
they themselves had previously received Tdap and Flu 
vaccines.
Prior receipt of adolescent vaccines
In the pre-intervention survey, Tdap and Influenza vac-
cines were reported to have been received by the par-
ticipants’ adolescent children in 77 and 64  % of cases, 
respectively. Prior receipt of MCV and HPV vaccines was 
Table 1 Demographic characteristics of  TeenVaxScene 
users and their adolescent children
a Parents could answer questions about as many adolescents as they had in 
their family
% (n)
Parent characteristics, n = 54
 Age in years (range, SD) 41.8 (18–54)
 Female gender 66 (31)
 Marital status
  Single 17 (8)
  Married/partnership 76 (36)
  Divorced/widowed 7 (3)
 Hispanic 10 (5)
 Race
  White 87 (41)
  Black 0
  All other choices 13 (8)
Education
 <High school 2 (1)
 High school graduate 11 (5)
 Some college 86 (41)
Prior personal experience with…
 Flu 83 (45)
 Tetanus 0
 Pertussis 22 (12)
 Meningitis 6 (3)
 Positive HPV test 7 (4)
 Genital warts 4 (2)
 Abnormal pap smear 30 (16)
 Cervical cancer 9 (5)
 None of the above 13 (7)
Prior experience of illness in their adolescent with…
 Flu 63 (34)
 Tetanus 0
 Pertussis 13 (7)
 Meningitis 2 (1)
 HPV-related health problems 0
 None of the above 31 (17)
Adolescent characteristics, n = 74a
Adolescent’s age in years (range) 13.6 (11–17)
 Female gender 51 (36)
 Adolescent’s health
  Very good 69 (51)
  Good 30 (22)
  Fair 1 (1)
  Poor 0
Medical conditions in adolescent
 Lung problems 15 (11)
 Neurologic problems 4 (3)
 Other chronic problem 4 (3)
 Allergy to eggs 0
 None of the above 78 (58)
Aware that there are vaccines recommended  
for this adolescent
84 (62)
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notably lower at 53 and 56  %, respectively. Among the 
39 adolescents whose parents reported prior HPV vac-
cination, 29 (59  %) reported that three doses had been 
received, 15 (28  %) indicated that their adolescent had 
not yet gotten three doses, but planned to do so, and one 
parent (3 %) indicated their adolescent had not yet gotten 
three doses and they did not plan to allow any more.
Attitudes about vaccines
Even before viewing the TeenVaxScene website, parents 
reported relatively high perceived effectiveness of the 
adolescent vaccines. Parents rated the Tdap and MCV 
vaccines as “very effective” or “effective” 73 % of the time, 
while Influenza and Tdap vaccines were rated this highly 
69 and 65 % of the time, respectively. More than half of 
parents (55  %) indicated they wanted more informa-
tion about how vaccines work, and 58  % indicated they 
wanted more information about vaccine safety.
Table  2 shows results of the pre-intervention survey 
regarding parents’ attitudes about vaccines in general, 
and for each vaccine the parent reported their adolescent 
had not yet received. As in other studies, [6, 20] a high 
proportion (69 %) indicated that a doctor’s recommenda-
tion was one of the most important factors in deciding 
about vaccines. However, a number of negative attitudes 
about vaccines were also identified. For example, one out 
of five parents worried that vaccines in general caused 
more harm than good. Moreover, a substantial minority 
of parents believed that vaccines in general might cause 
long term health problems for their child (15 %), that the 
HPV vaccine might make their adolescent think it was 
OK to have sex (23  %), and that the Influenza vaccine 
could cause the flu (34 %).
Immediate impact of TeenVaxScene on vaccination 
attitudes
Among the 54 parents who answered questions in the 
pre-intervention survey, 42 viewed at least one page of 
tailored content (Fig.  1). Of these, 16 (38  %) provided 
answers to the post-intervention survey to allow for 
assessment of the immediate impact of the TeenVaxScene 
website on vaccination intentions. As shown in Table 3, 
for three of the four vaccines (all except Tdap) there was 
a slightly higher mean vaccination intention after view-
ing the website than prior to viewing it. However, these 
results were not statistically significantly for any vaccine. 
Longer term impact of TeenVaxScene
Impact on vaccination attitudes
Among the 16 parents who completed the post-inter-
vention survey, 8 (50 %) completed the follow up survey 
administered 3  months after viewing TeenVaxScene. As 
shown in Table  4, none of the parents indicated in the 
follow-up survey that TeenVaxScene made them less 
likely to have their adolescent vaccinated. In fact, in sev-
eral cases, the website actually increased planned vac-
cination behavior (20–67  % of cases, depending on the 
vaccine, Table 4). This possible trend towards more posi-
tive vaccination intentions did not appear to be moder-
ated by changes in perceived effectiveness of the vaccines 
or general vaccination attitudes, as neither of these meas-
ures were substantially more positive when comparing 
responses in the pre-intervention and follow up surveys 
for these parents (data not shown).
Impact on vaccine uptake
There were 37 adolescent children whose parents used 
TeenVaxScene that had vaccination records available 
from the practice. Viewing TeenVaxScene did not appear 
to increase the likelihood that these adolescents got vac-
cinated on the day of their appointment (Table 5), or in 
the 3  months after the appointment (data not shown), 
when compared to adolescent patients seen in the clinic 
during the study period whose parents had not used 
TeenVaxScene, though this analysis was hindered by a 
small sample size.
Discussion
In this study we implemented and assessed an educa-
tional website for parents called TeenVaxScene that pro-
vided individually-tailored educational material about the 
adolescent vaccination platform. The goal of this study 
was to assess the characteristics of those who used this 
website, and its impact on parental vaccination attitudes, 
decision-making and behavior. Overall, utilization of the 
website was low and appeared to have minimal impact on 
these outcomes. Thus, in a sense, our study could be con-
sidered a ‘negative study’ in that, despite extensive efforts 
to engage parents to participate in the website (reported 
elsewhere, [17]), very few actually did. This negative find-
ing is important because iPad-based interventions have 
been successfully used in primary care settings for other 
health issues, and many researchers are currently exam-
ining the utility of web-based interventions to improve 
adolescent health [21–33]. Our study suggests that when 
it comes to educating parents about adolescent vaccines, 
passively placing an iPad or a kiosk in a waiting room is 
not likely to engage a high proportion of parents. Fur-
ther study is needed to better understand how to actively 
engage parents with this type of information.
A major limitation to drawing conclusions from this 
study was its small sample size. Although the clinics 
where the intervention was in place saw ~6700 adoles-
cents during the study period, only 54 parents completed 
the baseline survey portion of the intervention, and 
only 42 parents viewed tailored educational materials. 
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Table 2 Attitudes about vaccines among TeenVaxScene users
The number of respondents changes for each section as parents were only asked about vaccines they reported their adolescent had not received previously. All 
parents received the general vaccination attitudes questions. Bracketed responses denote tailoring of the question to the child’s gender and/or neurologic status
a Only respondents with sons were provided with this question, n = 19
b Only 40 respondents answered this question
c Only 37 respondents answered this question
Statement % (n) agree or 
strongly agree
General attitudes, n = 65
 I think vaccines may cause short-term problems (example: fever or pain) 42 (27)
 I think vaccines may cause serious long term health problems for [child’s name] 15 (10)
 Many of my friends are not getting their children vaccinated 9 (6)
 Having [child’s name]’s doctor recommend a vaccine is one of the most important factors in deciding to get [him/her] vaccinated 69 (45)
 I worry that vaccines may cause more health problems for [child’s name] than benefit 20 (13)
HPV vaccine, n = 42
 I worry that [child’s name] may be at risk for genital warts, [(female): cervical cancer or other cancers related to HPV]
OR
[(male): cancers related to HPV, or may transmit the infection to others]
17 (7)
 I worry that the HPV vaccine will give [child’s name] the HPV virus 4 (2)
 I worry that [child’s name] will have reproductive problems if he/she gets the HPV vaccine 7 (3)
 I worry that the HPV vaccine will cause immune problems for [child’s name] 7 (3)
 I worry that if [[child’s name] got the HPV vaccine, then [he/she] would get neurologic problems] or [his/her neurologic problems 
would worsen]
9 (4)
 I don’t think [my son] would get much benefit from getting the HPV vaccinea 10 (2)
 I think that giving the HPV vaccine to [child’s name] may make [him or her] think it is OK to have sexb 23 (9)
 I think [child’s name] is too young to get a vaccine for a sexually transmitted infection like HPVb 23 (9)
 I am concerned that the HPV vaccine costs more than I can payb 13 (5)
 The HPV vaccine is so new that I want to wait a while before deciding if [child’s name] should get itc 27 (10)
 I need more information about the HPV vaccine before deciding whether or not to give [child’s name] the vaccinec 27 (10)
 Many of my friends are against giving the HPV vaccine to adolescentsc 7 (3)
 I would regret it if [child’s name] did not get the vaccine and later got a health problem related to HPVc 68 (25)
Tdap vaccine, n = 14
 I worry that [child’s name] may get tetanus 1 day 35 (5)
 I worry that [child’s name] may be exposed to pertussis (whooping cough) 43 (6)
 I worry that the Tdap vaccine is not safe for [child’s name] 21 (3)
 I think that giving [child’s name] the Tdap vaccine is more harmful to [him/her] than not giving it 21 (3)
 I would have [child’s name] get the Tdap vaccine because it is required by [his/her] school 64 (9)
Meningococcal vaccine, n = 22
 I worry that [child’s name] may be at risk for getting meningitis 14 (3)
 I worry that the meningococcal vaccine is not safe for [child’s name] 14 (3)
 I think that giving [child’s name] the meningococcal vaccine is more harmful to [him/her] than not giving it 10 (2)
 I would have [child’s name] get the meningococcal vaccine because it is required by [his/her] school 55 (12)
 I worry that if [child’s name] got the meningococcal vaccine, then [[he/she] would get neurologic problems] or [his/her neurologic 
problems would worsen]
10 (2)
Flu vaccine, n = 18
 I worry that [child’s name] may be at risk for getting the flu 24 (6)
 I think the flu vaccine can cause [child’s name] to get the flu 34 (6)
 I worry that if [child’s name]got the flu vaccine [he/she would get neurologic problems or his/her neurologic problems would 
worsen]
22 (4)
 I don’t think the flu vaccine is safe 16 (3)
 It is a hassle to get this vaccine every year 16 (3)
 I think it is better for [child’s name] to have the flu than get the flu vaccine 11 (2)
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As described previously [17], a number of different and 
increasingly intensive recruitment strategies were used 
to try and engage parents with the intervention. Despite 
this, the level of engagement with the intervention was 
disappointingly low, and significantly less that the level 
our study was powered for (n = 300). Future research will 
be needed to understand other ways such an intervention 
might be better disseminated—for example through pre-
visit communication (i.e., emailed appointment remind-
ers). However, it is important to note that when it comes 
to vaccination, interventions with even small impacts, or 
used by only small subset of the population can be poten-
tially useful. This is because, with millions of adolescents 
being recommended for vaccines each year, interventions 
that provide even incremental improvements in vaccine 
uptake can lead to several thousands more teens getting 
their recommended vaccines. Thus, a potentially impor-
tant finding from our study is the non-statistically-sig-
nificant trend for increased vaccination intentions after 
viewing the TeenVaxScene website. It is possible that with 
a larger sample size (for example if TeenVaxScene was 
available to the general public), improvements in vacci-
nation intention following use of TeenVaxScene would be 
statistically significant, which would be in keeping with 
our prior studies [15, 16]. However, an important caveat 
is that because the intervention was passively delivered, 
there was likely bias in the those who chose to use it—the 
intervention may have been more compelling to those 
who were inherently more interested in, and/or more 
willing to vaccinate, or alternatively, to those with strong 
convictions against vaccination that would be unlikely to 
be swayed by such an intervention.
Overall the attitudes of parents using TeenVaxScene 
were generally positive—most parents perceived vac-
cines as highly effective, and most of their adolescents 
had received at least one recommended adolescent vac-
cine. However, there were notable exceptions. For exam-
ple, one out of five parents agreed or strongly agreed that 
“vaccines may cause more health problems than benefit” 
and more than one out of ten parents agreed or strongly 
agreed that any given adolescent vaccine was “unsafe.” 
The combination of prevalent negative attitudes about 
vaccines combined with high levels of reported vaccine 
uptake suggest that our intervention may appeal most 
to the “fence sitter” parent—that is, a parent who has 
enough concerns about vaccines that they are at risk of 
becoming a vaccine refuser in the future, though they 
are currently (mostly) following the recommend vac-
cination schedule [34]. Vaccine hesitancy is recognized 
as a spectrum of beliefs ranging from refusal of all vac-
cines to acceptance of all vaccines though with significant 
trepidation [35]. Prior research suggests that the “fence 
sitter” group of parents may be the most amenable to 
educational interventions such as TeenVaxScene as these 
groups have generally positive attitudes about vaccines, 
Parcipant self directs to the 
iPad
(n=199)
Eligible parcipant completes 
pre-intervetnion survey 
n=54






Parent completes follow-up 
survey
n=7
Fig 1 Participant flow through the various components of the Teen-
VaxScene intervention
Table 3 Reported mean likelihood of having adolescent vaccinated before and after viewing TeenVaxScene
Analysis limited to participants who had data for both the pre-intervention and post-intervention surveys. The number of respondents varies by vaccine as parents 
were only asked to report on those vaccines they indicated their adolescent had not yet received
Vaccine N for analysis Pre intervention mean Post intervention mean p value
HPV 16 6.025 6.69 0.244
Tdap 4 8.00 8.00 n/a
Meningococcal 10 6.30 6.80 0.177
Flu 7 3.42 4.00 0.532
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but need significant reassurance [34, 35]. Time con-
straints during clinical encounters have been reported by 
clinicians as a major barrier to addressing vaccine hesi-
tancy among parents [10, 36–38]. Providing an educa-
tional resource such as TeenVaxScene prior to a clinical 
encounter may be an effective way to alleviate the con-
cerns of “fence sitter” parents without adding significant 
time to the clinician–patient conversation. Our group 
currently has studies that are exploring this hypothesis 
directly.
Most of the users of TeenVaxScene in this study were 
educated, white females. This is not entirely surprising 
since mothers are known to be the parent most likely 
to take their child to the doctor, [39] and white was the 
predominant race among patients attending the clinical 
sites where the intervention was located. However, it was 
notable that a majority (86 %) of TeenVaxScene users had 
at least some college education, which differs from the 
demographics of the parent population at these clinics. 
Past research suggests that in the US vaccine hesitancy 
may be more common among more highly educated par-
ents [40]. Thus, even though the level of utilization of 
TeenVaxScene was low overall, our results could be con-
sistent with the notion that the intervention reached the 
“type” of parents (e.g., well-educated fence-sitters) who 
are most likely to have vaccine-related questions, con-
cerns or informational needs.
A very important thing to consider in any intervention 
study is unanticipated negative impacts resulting from 
the intervention. Vaccine hesitant parents frequently 
report that available vaccine information is biased, 
emphasizing only the benefits to vaccination while mini-
mizing or ignoring any side effects [41]. TeenVaxScene 
was designed with this in mind and special attention was 
given to trying to provide accurate, equal amounts of 
information about the pros and cons (risk of anaphylaxis, 
and short term side effects like fever, sore arm, headache, 
etc.) to vaccinating. Given this, one might hypothesize 
that providing extensive vaccine-related information to 
parents could actually increase their concerns about vac-
cines [42]. However, with the caveat that any results from 
our study should be considered cautiously given the small 
sample size, our very preliminary results do not suggest 
that TeenVaxScene causes negative vaccination beliefs 
and attitudes. For example, no parent reported in the fol-
low up survey that they were less likely to get a vaccine 
for their adolescent after viewing TeenVaxScene (and 
several reported they were more likely to get vaccinated), 
and there was no measurable negative impact on per-
ceived vaccine effectiveness, or general attitudes about 
vaccination.
In addition to the small sample size, there are other 
important limitations to this study that need to be con-
sidered. This pilot study was performed in a single geo-
graphic area, with minimal heterogeneity of the study 
population which limits the generalizability of the results. 
Also, there are known to be culturally-specific vaccina-
tion attitudes and beliefs [43–46] which would not likely 
be addressed by TeenVaxScene as it was designed for the 
general public. Finally, our website was available only in 
English and only on an iPad, and was therefore not likely 
useful for non-English speakers and those who were 
not familiar with how to use an iPad. Our sample could 
therefore have been biased towards more highly edu-
cated, computer savvy individuals, which may or may not 
be the group for which the information in the interven-
tion is most useful.
Conclusions
We developed a website called TeenVaxScene that pro-
vides individually-customized information about ado-
lescent vaccination to parents [17]. We found that the 
majority of users were highly educated females, con-
sistent with prior studies suggesting that this popu-
lation is most likely to have significant concerns or 
questions about vaccines. Overall, parents’ interac-
tion with TeenVaxScene was low, and had little impact 
Table 4 Impact of  TeenVaxScene on  planned vaccination 
behavior
Data reported for parents who responded to the follow up survey 2 months after 
viewing TeenVaxScene, and indicated that their adolescent had still not received 
the given vaccine. The number of respondents varies by vaccine as parents were 
only asked to report on those vaccines they indicated their adolescent had not 
yet received




Don’t know Less likely 
to get
HPV 5 1 4 0
Tdap 3 2 1 0
Meningococ-
cal
5 1 4 0
Flu 3 2 1 0
Table 5 Impact of TeenVaxScene on vaccine uptake
Among those eligible for the vaccine at the time of the visit, how many got a 
vaccine that day
Utilizers adolescents seen in the clinic during the study period whose parent 
used TeenVaxScene; Non-utilizers adolescents seen in the clinic during the study 
period whose parent did not use TeenVaxScene
*** Fisher’s exact test
Utilizers Non‑utilizers p value
Tdap 25 % (1/4) 35 % (695/1965) 0.99***
Flu 8 % (3/37) 25 % (1690/6712) 0.02
MCV 20 % (1/5) 38 % (823/2162) 0.66***
HPV 17 % (4/23) 19 % (969/5004) 0.99***
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on their vaccination attitudes, beliefs or behaviors, 
though there was a non-statistically significant trend for 
improved vaccination intentions following use of the 
website. Importantly, use of TeenVaxScene did not appear 
to worsen parents’ attitudes about vaccines. Larger stud-
ies are needed to understand the impact of this inter-
vention on parents’ vaccine-related attitudes and beliefs, 




The content and structure of “TeenVaxScene” has been 
described in detail elsewhere [17]. Briefly, this website 
creates individually-tailored content for parents that 
accounts for each person’s unique beliefs and experi-
ences related to adolescent Tdap, HPV, Influenza and 
MCV vaccination. The goal of TeenVaxScene is to pro-
vide information to parents to help address their unique 
concerns or questions they may have about adolescent 
vaccines, and ultimately to increase adolescent vaccina-
tion uptake.
Study setting
The TeenVaxScene website was provided via a kiosk 
or moveable iPad to parents of adolescents (ages 
11–17 years) in the clinic waiting rooms of three primary 
care pediatric clinics in the Denver metro area. Practices 
A and B had patient populations that were primarily pri-
vately insured whereas nearly half (45 %) of the patients 
seen in Practice C were insured by Medicaid. Cauca-
sian was the predominant race of adolescent patients at 
all three sites. All study activities were approved by the 
Colorado Multiple Institution Review Board (COMIRB) 
affiliated with the University of Colorado Denver.
Study design
This study included a pre-/post-intervention design com-
paring the attitudes and vaccination intentions of par-
ents before and after using the interventional website, 
and also a comparative cohort design whereby the vac-
cination status of children whose parents used the inter-
ventional website were compared to those age-eligible 
children seen in the clinic during the study period whose 
parents did not use the website.
Study flow
Figure  1 depicts the various components of the Teen-
VaxScene intervention, and the number of participants 
at each step. Interested parents self-directed to the 
kiosk and used TeenVaxScene prior to their adolescent’s 
scheduled appointment (n  =  199). After parents pro-
vided online informed consent for their participation in 
the study and approval to access their adolescent’s vac-
cination records, parents completed a brief “pre-inter-
vention” survey that collected demographic data about 
the parent and adolescent, and assessed initial attitudes 
about vaccines and vaccination intentions (n  =  54). As 
described previously, [17] the majority of parents were 
offered a $10 incentive for completing the pre-interven-
tion survey. An internal “tailoring engine” [18] used the 
data from the pre-intervention survey to generate a series 
of webpages that were specific to each parent. After view-
ing the tailored content (n = 42), parents were asked (but 
not required) to take a brief “post-intervention” survey 
that re-assessed vaccination intention (n = 16), and also 
queried about their willingness to receive a “follow up” 
survey (with an additional $10 incentive) via postal mail 
3  months after the date they used TeenVaxScene. The 
follow up survey (n = 8) re-assessed general vaccination 
attitudes, and collected data on the perceived usefulness 
of the intervention for making vaccination decisions. Up 
to three contact attempts were made via postal mail for 
the follow up survey. All survey materials are available 
from the authors upon request.
Outcome measures
Attitudes about vaccines in general, and each vaccine 
specifically, were assessed by measuring agreement with 
a series statements using a 5-point Likert scale ranging 
from “strongly agree” to “strongly disagree.” All parents 
received statements regarding their attitudes about vac-
cines in general, but vaccine-specific statements were 
provided only to those parents reporting that their ado-
lescent had not yet received that particular vaccine. Due 
to the small sample size, categorical Likert responses 
were grouped for each question to improve statisti-
cal power. For the attitude assessment, responses were 
grouped as “strongly agree/agree” versus “neutral/disa-
gree/strongly disagree;” for the assessment of vaccine 
effectiveness responses were grouped as “very effective/
effective” versus “unsure/somewhat ineffective/very 
ineffective.” Vaccination intention was measured using 
a previously-described 11-point scale, where mean vac-
cination was calculated across participants for each 
vaccine, and higher values represented more positive 
vaccination intentions [19].
Vaccination status was assessed by linking unique 
identifying information (i.e., name and birthdate) of the 
children of parent participants who self-elected to use 
the website to the child’s medical records at that practice 
and to the state of Colorado’s Immunization Informa-
tion system. The comparison group was all age-eligible 
adolescents attending the clinic during the study period 
whose parents did not appear to have used the interven-
tion website. Based on what we had initially estimated 
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would be the sample size of those using the interven-
tion (n =  300) we had powered our study to be able to 
detect seven percentage point differences between chil-
dren of parents who did and did not use the intervention. 
However, the extremely poor uptake of the intervention 
meant our ability to find statistically significant differ-
ences between groups was severely limited, even if the 
percentage point variation between groups was large.
Data analysis
Descriptive statistics were generated for all demographic 
variables. Two-sided, paired Student t tests were used to 
compare mean vaccination intentions between the pre- 
and post-intervention surveys. Fisher’s exact tests were 
used to compare vaccination attitudes between the pre-
intervention and follow-up surveys. A p value of ≤0.05 
was considered statistically significant. All analyses were 
performed in either SAS 9.2 (Cary, NC) or STATA12 
(StataCorp LP).
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